| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription regulator activator activity | 1.90e-05 | 10 | 110 | 3 | GO:0140537 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.19e-04 | 46 | 110 | 4 | GO:0030020 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.25e-04 | 18 | 110 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.64e-04 | 210 | 110 | 7 | GO:0019903 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 4.82e-04 | 28 | 110 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | phosphatase binding | 6.52e-04 | 264 | 110 | 7 | GO:0019902 | |
| GeneOntologyMolecularFunction | metallocarboxypeptidase activity | 6.53e-04 | 31 | 110 | 3 | GO:0004181 | |
| GeneOntologyMolecularFunction | NAD binding | 7.08e-04 | 73 | 110 | 4 | GO:0051287 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 9.09e-04 | 78 | 110 | 4 | GO:0003725 | |
| GeneOntologyMolecularFunction | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity | 1.06e-03 | 9 | 110 | 2 | GO:0043878 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.10e-03 | 37 | 110 | 3 | GO:0045505 | |
| GeneOntologyBiologicalProcess | host-mediated regulation of intestinal microbiota composition | 1.72e-05 | 10 | 110 | 3 | GO:0048874 | |
| GeneOntologyCellularComponent | anchoring collagen complex | 8.35e-05 | 3 | 111 | 2 | GO:0030934 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 2.77e-04 | 5 | 111 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 4.13e-04 | 6 | 111 | 2 | GO:0005593 | |
| Domain | TSPN | 9.25e-06 | 23 | 110 | 4 | SM00210 | |
| Domain | - | 1.80e-05 | 27 | 110 | 4 | 3.30.160.20 | |
| Domain | dsRBD_dom | 2.09e-05 | 28 | 110 | 4 | IPR014720 | |
| Domain | ARM-type_fold | ATR USP9X IFT172 CUL9 FHOD3 HEATR5A ARMCX1 THADA EFR3B AGTPBP1 | 3.20e-05 | 339 | 110 | 10 | IPR016024 |
| Domain | Dynein_heavy_chain_D4_dom | 6.90e-05 | 14 | 110 | 3 | IPR024317 | |
| Domain | AAA_8 | 6.90e-05 | 14 | 110 | 3 | PF12780 | |
| Domain | DHC_fam | 8.59e-05 | 15 | 110 | 3 | IPR026983 | |
| Domain | Dynein_heavy_dom | 8.59e-05 | 15 | 110 | 3 | IPR004273 | |
| Domain | Dynein_heavy | 8.59e-05 | 15 | 110 | 3 | PF03028 | |
| Domain | ARM-like | 1.97e-04 | 270 | 110 | 8 | IPR011989 | |
| Domain | DS_RBD | 2.45e-04 | 21 | 110 | 3 | PS50137 | |
| Domain | Peptidase_M14 | 3.23e-04 | 23 | 110 | 3 | PF00246 | |
| Domain | Peptidase_M14 | 3.23e-04 | 23 | 110 | 3 | IPR000834 | |
| Domain | - | 3.44e-04 | 222 | 110 | 7 | 1.25.10.10 | |
| Domain | Laminin_G | 3.78e-04 | 58 | 110 | 4 | IPR001791 | |
| Domain | Collagen | 1.60e-03 | 85 | 110 | 4 | IPR008160 | |
| Domain | Collagen | 1.60e-03 | 85 | 110 | 4 | PF01391 | |
| Domain | Fib_collagen_C | 1.83e-03 | 11 | 110 | 2 | IPR000885 | |
| Domain | COLFI | 1.83e-03 | 11 | 110 | 2 | PF01410 | |
| Domain | NC1_FIB | 1.83e-03 | 11 | 110 | 2 | PS51461 | |
| Domain | Fib_collagen_C | 1.83e-03 | 11 | 110 | 2 | PD002078 | |
| Domain | COLFI | 1.83e-03 | 11 | 110 | 2 | SM00038 | |
| Domain | PHD | 1.89e-03 | 89 | 110 | 4 | SM00249 | |
| Domain | Znf_PHD | 2.05e-03 | 91 | 110 | 4 | IPR001965 | |
| Domain | Ribosomal_L7Ae/L30e/S12e/Gad45 | 2.18e-03 | 12 | 110 | 2 | IPR004038 | |
| Domain | ZF_PHD_2 | 2.40e-03 | 95 | 110 | 4 | PS50016 | |
| Domain | - | 2.40e-03 | 95 | 110 | 4 | 2.60.120.200 | |
| Domain | ZF_PHD_1 | 2.50e-03 | 96 | 110 | 4 | PS01359 | |
| Domain | WW | 2.67e-03 | 47 | 110 | 3 | PF00397 | |
| Domain | WW | 2.84e-03 | 48 | 110 | 3 | SM00456 | |
| Domain | Dynein_HC_stalk | 2.99e-03 | 14 | 110 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.99e-03 | 14 | 110 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.99e-03 | 14 | 110 | 2 | PF08393 | |
| Domain | MT | 2.99e-03 | 14 | 110 | 2 | PF12777 | |
| Domain | ATPase_dyneun-rel_AAA | 2.99e-03 | 14 | 110 | 2 | IPR011704 | |
| Domain | AAA_5 | 2.99e-03 | 14 | 110 | 2 | PF07728 | |
| Domain | WW_DOMAIN_2 | 3.37e-03 | 51 | 110 | 3 | PS50020 | |
| Domain | WW_DOMAIN_1 | 3.37e-03 | 51 | 110 | 3 | PS01159 | |
| Domain | L30e-like | 3.43e-03 | 15 | 110 | 2 | IPR029064 | |
| Domain | FH2 | 3.43e-03 | 15 | 110 | 2 | PS51444 | |
| Domain | - | 3.43e-03 | 15 | 110 | 2 | 3.30.1330.30 | |
| Domain | FH2_Formin | 3.43e-03 | 15 | 110 | 2 | IPR015425 | |
| Domain | FH2 | 3.43e-03 | 15 | 110 | 2 | PF02181 | |
| Domain | FH2 | 3.43e-03 | 15 | 110 | 2 | SM00498 | |
| Domain | WW_dom | 3.56e-03 | 52 | 110 | 3 | IPR001202 | |
| Domain | Post-SET_dom | 3.91e-03 | 16 | 110 | 2 | IPR003616 | |
| Domain | PostSET | 3.91e-03 | 16 | 110 | 2 | SM00508 | |
| Domain | Ald_DH_CS_GLU | 3.91e-03 | 16 | 110 | 2 | IPR029510 | |
| Domain | POST_SET | 3.91e-03 | 16 | 110 | 2 | PS50868 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 4.41e-03 | 17 | 110 | 2 | IPR012317 | |
| Domain | PARP_CATALYTIC | 4.41e-03 | 17 | 110 | 2 | PS51059 | |
| Domain | PARP | 4.41e-03 | 17 | 110 | 2 | PF00644 | |
| Domain | Ald_DH_CS_CYS | 4.41e-03 | 17 | 110 | 2 | IPR016160 | |
| Domain | - | 4.41e-03 | 17 | 110 | 2 | 3.90.228.10 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 4.95e-03 | 18 | 110 | 2 | PS00687 | |
| Domain | Zn_pept | 4.95e-03 | 18 | 110 | 2 | SM00631 | |
| Domain | - | 4.95e-03 | 18 | 110 | 2 | 3.30.470.20 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 4.95e-03 | 18 | 110 | 2 | PS00070 | |
| Domain | Ald_DH_C | 5.51e-03 | 19 | 110 | 2 | IPR016163 | |
| Domain | Ald_DH_N | 5.51e-03 | 19 | 110 | 2 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 5.51e-03 | 19 | 110 | 2 | IPR016161 | |
| Domain | - | 5.51e-03 | 19 | 110 | 2 | 3.40.605.10 | |
| Domain | Aldedh | 5.51e-03 | 19 | 110 | 2 | PF00171 | |
| Domain | Aldehyde_DH_dom | 5.51e-03 | 19 | 110 | 2 | IPR015590 | |
| Domain | - | 5.51e-03 | 19 | 110 | 2 | 3.40.309.10 | |
| Domain | CARBOXYPEPT_ZN_2 | 5.51e-03 | 19 | 110 | 2 | PS00133 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 9.58e-05 | 41 | 83 | 4 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.27e-04 | 44 | 83 | 4 | M27812 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.51e-04 | 46 | 83 | 4 | M198 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.09e-04 | 50 | 83 | 4 | MM14796 | |
| Pubmed | COL5A1 SERBP1 TCF20 ACLY USP9X TUT7 RSF1 CUL9 PAICS ESF1 IQGAP1 STAU1 CEP170 XRCC6 SON | 3.17e-09 | 653 | 112 | 15 | 22586326 | |
| Pubmed | 7.06e-09 | 8 | 112 | 4 | 18816857 | ||
| Pubmed | SERBP1 RPAP3 ACLY USP9X ETF1 CPD PAICS ADCY9 ADD1 IQGAP1 STAU1 CEP170 PARP1 EFR3B XRCC6 | 9.34e-09 | 708 | 112 | 15 | 39231216 | |
| Pubmed | CLGN TCF20 RPAP3 TEX2 TUT7 UBXN8 SAV1 ADCY9 ADD1 STAU1 CEP170 SETD2 GTF2F1 SECISBP2 AGTPBP1 | 1.48e-08 | 733 | 112 | 15 | 34672954 | |
| Pubmed | SERBP1 SUPT20H TCF20 ATR ETF1 RSF1 PPWD1 ESF1 IQGAP1 RTF1 PARP1 SETD2 GTF2F1 CAVIN1 XRCC6 SON | 1.68e-07 | 1014 | 112 | 16 | 32416067 | |
| Pubmed | SERBP1 TCF20 RPAP3 ACLY USP9X PAICS ADD1 ESF1 CEP170 KMT2C SETD2 TET1 | 2.24e-07 | 549 | 112 | 12 | 38280479 | |
| Pubmed | CCPG1 RPAP3 TEX2 MRPL44 UBXN8 CPD ADCY9 ADD1 ESF1 STAU1 PARP1 THADA DNAJC28 DNAJA4 EFR3B COL14A1 ALDH2 XRCC6 AGTPBP1 | 2.76e-07 | 1487 | 112 | 19 | 33957083 | |
| Pubmed | 1.02e-06 | 102 | 112 | 6 | 11214970 | ||
| Pubmed | HSP90AB4P ACLY USP9X IFT172 ETF1 PAICS ADD1 IQGAP1 STAU1 PARP1 XRCC6 SON | 1.09e-06 | 638 | 112 | 12 | 33239621 | |
| Pubmed | 1.59e-06 | 250 | 112 | 8 | 33536335 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SERBP1 RPAP3 ACLY TUT7 ETF1 PAICS ADD1 ESF1 IQGAP1 STAU1 CEP170 PARP1 KCTD10 CSTA CAVIN1 XRCC6 | 2.81e-06 | 1257 | 112 | 16 | 36526897 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SERBP1 HSP90AB4P ATR ACLY USP9X MRPL44 ETF1 PAICS ESF1 IQGAP1 STAU1 PARP1 THADA CSTA ALDH2 ALDH1B1 XRCC6 | 3.18e-06 | 1425 | 112 | 17 | 30948266 |
| Pubmed | COL11A1 ACLY TUT7 CUL9 PAICS ESF1 IQGAP1 PARP1 C17orf75 CAVIN1 ALDH2 ALDH1B1 XRCC6 | 4.17e-06 | 859 | 112 | 13 | 31536960 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | FLT1 SUPT20H USP9X ETF1 PTPN22 PAICS RTF1 KMT2C DNAH12 XIRP2 | 5.00e-06 | 497 | 112 | 10 | 36774506 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | RPAP3 TEX2 TUT7 MRPL44 CPD CHML ADCY9 ESF1 STAU1 PARP1 THADA DNAJC28 SECISBP2 ALDH2 ALDH1B1 XRCC6 SON | 6.05e-06 | 1496 | 112 | 17 | 32877691 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TCF20 RPAP3 ACLY TUT7 RSF1 ARMCX1 PAICS ESF1 IQGAP1 STAU1 PARP1 CSTA CAVIN1 ALDH1B1 XRCC6 SON | 7.13e-06 | 1353 | 112 | 16 | 29467282 |
| Pubmed | Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis. | 7.98e-06 | 84 | 112 | 5 | 19135240 | |
| Pubmed | COL11A1 A1CF SERBP1 ACLY TUT7 ADD1 IQGAP1 STAU1 CEP170 PARP1 CSTA COL14A1 CAVIN1 XRCC6 AGTPBP1 SON | 8.40e-06 | 1371 | 112 | 16 | 36244648 | |
| Pubmed | EGR1 and EGR2 involvement in vertebrate tendon differentiation. | 9.08e-06 | 13 | 112 | 3 | 21173153 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SERBP1 RPAP3 ACLY ETF1 RSF1 ADD1 ESF1 STAU1 CEP170 PARP1 SETD2 XRCC6 SON | 1.02e-05 | 934 | 112 | 13 | 33916271 |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 15609093 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 25047496 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 23667679 | ||
| Pubmed | Structure of a full-length cDNA clone for the pro-alpha1(V/XI) collagen chain of red seabream. | 1.03e-05 | 2 | 112 | 2 | 11342118 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 17960519 | ||
| Pubmed | PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. | 1.03e-05 | 2 | 112 | 2 | 20832725 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 29447383 | ||
| Pubmed | Abnormal corneal endothelial maturation in collagen XII and XIV null mice. | 1.03e-05 | 2 | 112 | 2 | 23599329 | |
| Pubmed | Modulation of spectrin-actin assembly by erythrocyte adducin. | 1.03e-05 | 2 | 112 | 2 | 3600811 | |
| Pubmed | 5mC-hydroxylase activity is influenced by the PARylation of TET1 enzyme. | 1.03e-05 | 2 | 112 | 2 | 26136340 | |
| Pubmed | Rtf1 Transcriptionally Regulates Neonatal and Adult Cardiomyocyte Biology. | 1.03e-05 | 2 | 112 | 2 | 37233188 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 27035649 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 21256093 | ||
| Pubmed | Comparative genomics, molecular evolution and computational modeling of ALDH1B1 and ALDH2. | 1.03e-05 | 2 | 112 | 2 | 23247008 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 32300124 | ||
| Pubmed | Interaction between PARP-1 and ATR in mouse fibroblasts is blocked by PARP inhibition. | 1.03e-05 | 2 | 112 | 2 | 18691676 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 34074749 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CCPG1 SERBP1 ACLY SPTA1 ETF1 PAICS IQGAP1 STAU1 EPG5 DNAH1 PARP1 XRCC6 | 1.19e-05 | 807 | 112 | 12 | 30575818 |
| Pubmed | SERBP1 ACLY MRPL44 ETF1 PPWD1 PAICS IQGAP1 STAU1 CEP170 PARP1 C17orf75 XRCC6 | 1.22e-05 | 809 | 112 | 12 | 32129710 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SERBP1 RPAP3 ACLY USP9X ETF1 PPWD1 PAICS IQGAP1 RTF1 CEP170 PARP1 GTF2F1 DNAJA4 CAVIN1 XRCC6 SON | 1.24e-05 | 1415 | 112 | 16 | 28515276 |
| Pubmed | TCF20 BICRA ACLY ETF1 PTPN22 PPWD1 PAICS IQGAP1 STAU1 CEP170 KMT2C PARP1 GTF2F1 XRCC6 | 1.28e-05 | 1103 | 112 | 14 | 34189442 | |
| Pubmed | FLT1 CCPG1 COL11A1 COL12A1 SUPT20H RSF1 SAV1 KMT2C THADA C17orf75 CSTA | 1.46e-05 | 689 | 112 | 11 | 36543142 | |
| Pubmed | 1.63e-05 | 47 | 112 | 4 | 8812413 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | TCF20 ACLY ETF1 PAICS ESF1 IQGAP1 STAU1 RTF1 PARP1 CAVIN1 ALDH1B1 XRCC6 SON | 1.86e-05 | 989 | 112 | 13 | 36424410 |
| Pubmed | SERBP1 CLGN MRPL44 PAICS IQGAP1 STAU1 CEP170 PARP1 ALDH1B1 XRCC6 SON | 2.33e-05 | 725 | 112 | 11 | 27025967 | |
| Pubmed | Does 3D Phenotyping Yield Substantial Insights in the Genetics of the Mouse Mandible Shape? | 2.56e-05 | 18 | 112 | 3 | 26921296 | |
| Pubmed | Absence of PARP-1 affects Cxcl12 expression by increasing DNA demethylation. | 3.08e-05 | 3 | 112 | 2 | 30697918 | |
| Pubmed | IER5 is involved in DNA Double-Strand Breaks Repair in Association with PAPR1 in Hela Cells. | 3.08e-05 | 3 | 112 | 2 | 29104487 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 19147789 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 28212632 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 17318223 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 12693930 | ||
| Pubmed | Soluble Alpha-Klotho Alleviates Cardiac Fibrosis without Altering Cardiomyocytes Renewal. | 3.08e-05 | 3 | 112 | 2 | 32235720 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 29367615 | ||
| Pubmed | Ku70 Binding to YAP Alters PARP1 Ubiquitination to Regulate Genome Stability and Tumorigenesis. | 3.08e-05 | 3 | 112 | 2 | 38862269 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 10400681 | ||
| Pubmed | cDNA sequence and expression of the mouse alpha1(V) collagen gene (Col5a1). | 3.08e-05 | 3 | 112 | 2 | 9582436 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 22197999 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 36553626 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 18782342 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 17471563 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 34009784 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 23454351 | ||
| Pubmed | Ets-1 interacts through a similar binding interface with Ku70 and Poly (ADP-Ribose) Polymerase-1. | 3.08e-05 | 3 | 112 | 2 | 29912634 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 22573329 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 1306115 | ||
| Pubmed | ATM Kinase Is Required for Telomere Elongation in Mouse and Human Cells. | 3.08e-05 | 3 | 112 | 2 | 26586427 | |
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 35393951 | ||
| Pubmed | 3.08e-05 | 3 | 112 | 2 | 26876283 | ||
| Pubmed | 3.40e-05 | 496 | 112 | 9 | 31343991 | ||
| Pubmed | 3.79e-05 | 503 | 112 | 9 | 36217030 | ||
| Pubmed | 4.79e-05 | 22 | 112 | 3 | 27527664 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 5.11e-05 | 202 | 112 | 6 | 33005030 | |
| Pubmed | 5.41e-05 | 407 | 112 | 8 | 12693553 | ||
| Pubmed | SERBP1 KCTD13 ACLY USP9X SPTA1 ETF1 ADD1 IQGAP1 STAU1 CEP170 PARP1 KCTD10 ALDH2 ALDH1B1 AGTPBP1 | 5.65e-05 | 1431 | 112 | 15 | 37142655 | |
| Pubmed | Collagen XI chain misassembly in cartilage of the chondrodysplasia (cho) mouse. | 6.14e-05 | 4 | 112 | 2 | 17683922 | |
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 17187679 | ||
| Pubmed | Common variants at 12q24 are associated with drinking behavior in Han Chinese. | 6.14e-05 | 4 | 112 | 2 | 23364009 | |
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 15650754 | ||
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 20205700 | ||
| Pubmed | Interactions between collagen gene variants and risk of anterior cruciate ligament rupture. | 6.14e-05 | 4 | 112 | 2 | 25073002 | |
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 18069692 | ||
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 29158260 | ||
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 8626479 | ||
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 23624467 | ||
| Pubmed | DNA-Dependent protein kinase is not required for efficient lentivirus integration. | 6.14e-05 | 4 | 112 | 2 | 11070027 | |
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 14734561 | ||
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 22163289 | ||
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 25943351 | ||
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 22383705 | ||
| Pubmed | ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status. | 6.14e-05 | 4 | 112 | 2 | 23548269 | |
| Pubmed | 6.14e-05 | 4 | 112 | 2 | 10950304 | ||
| Pubmed | 6.26e-05 | 24 | 112 | 3 | 25344368 | ||
| Pubmed | TCF20 USP9X RPS6KA2 ETF1 HECTD4 CNRIP1 ADD1 IQGAP1 CEP170 PARP1 DNAJA4 XRCC6 | 6.63e-05 | 963 | 112 | 12 | 28671696 | |
| Pubmed | 6.82e-05 | 131 | 112 | 5 | 35356984 | ||
| Pubmed | 7.10e-05 | 25 | 112 | 3 | 20696915 | ||
| Pubmed | Xrcc4 physically links DNA end processing by polynucleotide kinase to DNA ligation by DNA ligase IV. | 7.10e-05 | 25 | 112 | 3 | 15385968 | |
| Pubmed | COL5A1 CCPG1 COL12A1 HSP90AB4P ACLY CPD PAICS CEP170 PARP1 DNAJA4 MAPKAPK3 CSTA CAVIN1 XRCC6 | 7.47e-05 | 1297 | 112 | 14 | 33545068 | |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 7.87e-05 | 135 | 112 | 5 | 31077711 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 8.19e-05 | 220 | 112 | 6 | 35785414 | |
| Interaction | SHC1 interactions | FLT1 ACLY USP9X SPTA1 MRPL44 CUL9 PAICS CEACAM1 IQGAP1 GHR CEP170 CD22 | 8.29e-07 | 362 | 112 | 12 | int:SHC1 |
| Interaction | SIRT7 interactions | COL5A1 SERBP1 TCF20 ATR ACLY USP9X TUT7 RSF1 CUL9 PAICS ESF1 IQGAP1 STAU1 CEP170 XRCC6 SON | 3.54e-06 | 744 | 112 | 16 | int:SIRT7 |
| Interaction | PHGDH interactions | SERBP1 KCTD13 RPAP3 STAU1 PARP1 DNAJA4 TRIM55 CSTA ALDH1B1 XRCC6 SON | 1.00e-05 | 385 | 112 | 11 | int:PHGDH |
| Interaction | SPTA1 interactions | 1.41e-05 | 94 | 112 | 6 | int:SPTA1 | |
| Interaction | WARS1 interactions | 1.44e-05 | 197 | 112 | 8 | int:WARS1 | |
| Interaction | COL11A1 interactions | 1.93e-05 | 29 | 112 | 4 | int:COL11A1 | |
| Interaction | KCNA3 interactions | SERBP1 RPAP3 ACLY USP9X ETF1 CPD PAICS ADCY9 ADD1 IQGAP1 STAU1 CEP170 KMT2C PARP1 EFR3B XRCC6 | 2.52e-05 | 871 | 112 | 16 | int:KCNA3 |
| Interaction | YAP1 interactions | SERBP1 TCF20 RPAP3 ACLY USP9X SAV1 PAICS ADD1 ESF1 IQGAP1 RTF1 CEP170 KMT2C PARP1 SETD2 TET1 CAVIN1 XRCC6 | 3.28e-05 | 1095 | 112 | 18 | int:YAP1 |
| Interaction | GPD2 interactions | 3.63e-05 | 111 | 112 | 6 | int:GPD2 | |
| Interaction | STIP1 interactions | KCTD13 HSP90AB4P RPAP3 TEX2 ACLY USP9X IFT172 ETF1 PAICS ADD1 IQGAP1 STAU1 PARP1 KCTD10 ALDH1B1 XRCC6 SON | 3.96e-05 | 1006 | 112 | 17 | int:STIP1 |
| Interaction | PTPN11 interactions | 3.96e-05 | 368 | 112 | 10 | int:PTPN11 | |
| Interaction | CDC37 interactions | SERBP1 TCF20 KCTD13 HSP90AB4P RPAP3 ACLY RPS6KA2 PAICS PARP1 GTF2F1 CAVIN1 ZBED1 XRCC6 | 6.09e-05 | 645 | 112 | 13 | int:CDC37 |
| Interaction | KIFBP interactions | 6.64e-05 | 180 | 112 | 7 | int:KIFBP | |
| Interaction | PDIA3 interactions | SERBP1 COL12A1 SUPT20H KCTD13 ACLY KLF3 PAICS DNAH14 THADA ALDH1B1 XRCC6 | 6.98e-05 | 476 | 112 | 11 | int:PDIA3 |
| Interaction | HYOU1 interactions | 7.00e-05 | 317 | 112 | 9 | int:HYOU1 | |
| Interaction | MSX2 interactions | 1.10e-04 | 195 | 112 | 7 | int:MSX2 | |
| GeneFamily | Collagens | 3.51e-05 | 46 | 73 | 4 | 490 | |
| GeneFamily | Dyneins, axonemal | 4.12e-05 | 17 | 73 | 3 | 536 | |
| GeneFamily | Mitogen-activated protein kinase-activated protein kinases | 8.64e-04 | 11 | 73 | 2 | 1156 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 2.10e-03 | 17 | 73 | 2 | 684 | |
| GeneFamily | Aldehyde dehydrogenases | 2.63e-03 | 19 | 73 | 2 | 398 | |
| GeneFamily | Carboxypeptidases | 3.21e-03 | 21 | 73 | 2 | 1321 | |
| GeneFamily | Pseudoautosomal region 1|Solute carriers | 4.54e-03 | 25 | 73 | 2 | 715 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | ATR RPAP3 USP9X TENT5A TUT7 RSF1 PPWD1 ESF1 CEP170 CROT DNAJA4 ALDH2 AGTPBP1 SON | 8.29e-07 | 656 | 112 | 14 | M18979 |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 2.24e-06 | 198 | 112 | 8 | M8624 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_DN | 2.24e-06 | 198 | 112 | 8 | M9234 | |
| Coexpression | GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP | 4.18e-06 | 152 | 112 | 7 | M2938 | |
| Coexpression | GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP | 9.06e-06 | 171 | 112 | 7 | M2947 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | FLT1 CCPG1 COL12A1 TEX2 USP9X TENT5A TUT7 KLF3 HEATR5A PARP14 ARMCX1 KMT2C CAVIN1 SON | 1.71e-05 | 854 | 112 | 14 | M1533 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | KDM5B CCPG1 COL11A1 SERBP1 KCTD13 TEX2 TENT5A UBXN8 RSF1 HECTD4 CNRIP1 FHOD3 CHML ADCY9 EFR3B ANKRD12 | 1.83e-05 | 1102 | 112 | 16 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | KDM5B CCPG1 COL11A1 SERBP1 KCTD13 TEX2 TENT5A UBXN8 RSF1 HECTD4 CNRIP1 FHOD3 CHML ADCY9 EFR3B ANKRD12 | 2.33e-05 | 1124 | 112 | 16 | MM1070 |
| Coexpression | GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_DN | 2.34e-05 | 198 | 112 | 7 | M9882 | |
| Coexpression | PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP | 2.45e-05 | 134 | 112 | 6 | M2185 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_UP | 2.50e-05 | 200 | 112 | 7 | M3636 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | FLT1 CCPG1 COL12A1 TEX2 USP9X TENT5A TUT7 KLF3 HEATR5A PARP14 ARMCX1 KMT2C CAVIN1 SON | 2.62e-05 | 888 | 112 | 14 | MM1018 |
| Coexpression | PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP | 2.77e-05 | 137 | 112 | 6 | MM886 | |
| Coexpression | NABA_COLLAGENS | 3.43e-05 | 43 | 112 | 4 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 3.76e-05 | 44 | 112 | 4 | M3005 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL5A1 FLT1 COL12A1 RPS6KA2 CNRIP1 ARMCX1 XIRP2 TET1 COL14A1 CAVIN1 | 6.31e-05 | 505 | 112 | 10 | M39167 |
| Coexpression | SMIRNOV_RESPONSE_TO_IR_6HR_UP | 8.66e-05 | 168 | 112 | 6 | M2588 | |
| Coexpression | GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP | 1.90e-04 | 194 | 112 | 6 | M3540 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN | 1.90e-04 | 194 | 112 | 6 | M7306 | |
| Coexpression | GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP | 1.95e-04 | 195 | 112 | 6 | M3138 | |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP | 2.12e-04 | 198 | 112 | 6 | M5222 | |
| Coexpression | GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN | 2.18e-04 | 199 | 112 | 6 | M7099 | |
| Coexpression | GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_DN | 2.18e-04 | 199 | 112 | 6 | M8707 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 2.20e-04 | 69 | 112 | 4 | M10165 | |
| Coexpression | GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_UP | 2.24e-04 | 200 | 112 | 6 | M6437 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_DN | 2.24e-04 | 200 | 112 | 6 | M4628 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP | 2.24e-04 | 200 | 112 | 6 | M8050 | |
| Coexpression | GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_UP | 2.24e-04 | 200 | 112 | 6 | M9080 | |
| Coexpression | GSE17721_CTRL_VS_LPS_4H_BMDC_DN | 2.24e-04 | 200 | 112 | 6 | M3690 | |
| Coexpression | GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP | 2.24e-04 | 200 | 112 | 6 | M7489 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-08 | 188 | 112 | 8 | 40ce7125fca6f6b6b5cc1637c87d43c29b08f4f1 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-08 | 188 | 112 | 8 | ba7f7ce034c0f42742bf2461f68f8d343ee593a5 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.22e-08 | 193 | 112 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 4.24e-08 | 200 | 112 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-08 | 140 | 112 | 7 | e442c46979d725ec82f525a001c46d971fcade4d | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-07 | 189 | 112 | 7 | 2ce330d8078833c05775c481e73770f9ee4a5c88 | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-07 | 189 | 112 | 7 | 473c87036e04a058b4a5138438b7ba7e1e766799 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-07 | 194 | 112 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.90e-06 | 146 | 112 | 6 | 26493014daa432db721613ef480d133f3da9eb58 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-NK_CD56bright|ICU-NoSEP / Disease, Lineage and Cell Type | 4.13e-06 | 167 | 112 | 6 | f4f188a8efca8cdd0ecfb857fe4538c10847eadd | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.58e-06 | 176 | 112 | 6 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 184 | 112 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_MEMP|bone_marrow / Manually curated celltypes from each tissue | 7.20e-06 | 184 | 112 | 6 | b81a2a95944cee8fec13d63dc0d95496e67aa937 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 184 | 112 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-06 | 184 | 112 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.14e-06 | 188 | 112 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 188 | 112 | 6 | 5b69de5baaac45a6d4daa1dbfcb70a7b2ae744ac | |
| ToppCell | COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.39e-06 | 189 | 112 | 6 | 2157a2d40613f7d5ce2e7dbd266df441e449cdaf | |
| ToppCell | COVID-19_Severe-HSPC|COVID-19_Severe / disease group, cell group and cell class | 8.39e-06 | 189 | 112 | 6 | 96015439971e2e5b8d6294ca5a6b873c7774e925 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.91e-06 | 191 | 112 | 6 | 7411b253b16e4d472be0925dee49188f0fd6b0b5 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 195 | 112 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.00e-05 | 195 | 112 | 6 | becad890a420267ca41e98e61a8da343b51e1945 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 195 | 112 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | (2)_Fibroblasts-(24)_Fibro-5|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.06e-05 | 197 | 112 | 6 | 83a4b79fbfa1cf63441dee4424c3b87c988287bf | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-05 | 198 | 112 | 6 | 9b29232c8b4dcbd81f450f47c3f79bf26c8fb583 | |
| ToppCell | facs-Lung-18m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-05 | 199 | 112 | 6 | c11e0044d3cc37f6bb26df033ad4448b419addfc | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-NK_CD56bright|ICU-NoSEP / Disease, condition lineage and cell class | 1.16e-05 | 200 | 112 | 6 | c2df917900872453ea17a39928e39d071a6d3339 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.76e-05 | 149 | 112 | 5 | e99b7cd3728ce76b365526734c2e7f845b2e62c8 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-hematopoietic_progenitor|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.76e-05 | 149 | 112 | 5 | 6a28dd4530ed411747fdfe743db138a1b5547ed7 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.26e-05 | 153 | 112 | 5 | b37a1ecad389d2848b8ca4d287823e8048207420 | |
| ToppCell | severe_influenza-cDC|World / disease group, cell group and cell class (v2) | 5.43e-05 | 161 | 112 | 5 | 802f8cafb5f499e3b2ec0193d6eb1ac9320b9287 | |
| ToppCell | Influenza_Severe-cDC|World / Disease group and Cell class | 5.93e-05 | 164 | 112 | 5 | c984228f73b9aa1aaf948541f64f41ed874770cd | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-05 | 168 | 112 | 5 | 08fe8fa43c343c03f9a2f0b982192fde04a7c027 | |
| ToppCell | facs-Heart-RV-24m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-05 | 168 | 112 | 5 | 831b000e26b4a7e7fdfa3988372e0281c45eadbb | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-05 | 168 | 112 | 5 | d4053b2fffb19e0376b8ceb92e87ec4447d96a3e | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 7.03e-05 | 170 | 112 | 5 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.23e-05 | 171 | 112 | 5 | a2938e56cb5749004317798dc7ac0f0c2d4d8ae0 | |
| ToppCell | ASK428-Immune-B_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.84e-05 | 174 | 112 | 5 | b5a7a612a515736cf3489afd0f6ad2054d54526f | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.84e-05 | 174 | 112 | 5 | 66df78280f657978c4a568010ae7d7943869af90 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 175 | 112 | 5 | 076ad81d6cbeea5512393d192af3ab5aa1f82975 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 175 | 112 | 5 | 445ccb9744a3a9ff37164c532afbe769d306b6c8 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.73e-05 | 178 | 112 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 8.73e-05 | 178 | 112 | 5 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.73e-05 | 178 | 112 | 5 | 6bef4ef48f649c6e38ae732bc08e6d7814db588b | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-CD45____B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 179 | 112 | 5 | 69c74b2ff43b43653005807654953daf21f932ec | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-VLMC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.96e-05 | 179 | 112 | 5 | 381ac15d59f31bc613828bdcfbc9192b106b4d18 | |
| ToppCell | facs-Heart-RV-24m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 179 | 112 | 5 | 6aa211670e5d6e013d0980967aa0a4f8f2905efe | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 179 | 112 | 5 | 7e6da098976c7801d31dcc0201f813d2bc8b07fc | |
| ToppCell | facs-Heart-RV-24m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 179 | 112 | 5 | cf4d3828a3ce97932c68d06f5c65a070fc6d832c | |
| ToppCell | COVID-19_Moderate-RBC|World / disease group, cell group and cell class | 8.96e-05 | 179 | 112 | 5 | 932fa98c0981ef8ef1e4945cdd4ae8c6c0858251 | |
| ToppCell | facs-Heart-RV-24m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 179 | 112 | 5 | f9bc76ff25f88ee44c72499a0df9dc16f519c4cb | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-hematopoietic_progenitor|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.20e-05 | 180 | 112 | 5 | f598bb9df0d784120847fada2d9a2a88b8b68cd1 | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 9.20e-05 | 180 | 112 | 5 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.20e-05 | 180 | 112 | 5 | b4fa047f271c7b56940bdc85c912f50aa5b5ca82 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Sc17a7.Calb1-Ddit4l_(Neurofilament,_Layer4?)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.27e-05 | 35 | 112 | 3 | afb8cd52dffd630ffe8e7812874d5fd52e0b6752 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 9.44e-05 | 181 | 112 | 5 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 9.69e-05 | 182 | 112 | 5 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | COVID-19_Severe-Hematopoietic_SC-HSPC|COVID-19_Severe / Disease group, lineage and cell class | 9.94e-05 | 183 | 112 | 5 | 4146b1c0e5f76d25226745abfa28f77127a444fc | |
| ToppCell | COVID-19_Moderate-RBC|COVID-19_Moderate / disease group, cell group and cell class | 9.94e-05 | 183 | 112 | 5 | 0dc337cd3f4f7964b0a268139c7ddc0f58b6a279 | |
| ToppCell | COVID-19_Severe-Hematopoietic_SC|COVID-19_Severe / Disease group, lineage and cell class | 9.94e-05 | 183 | 112 | 5 | 92aab7ce65aca17988bc2add4ff9fb8384e2c21b | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 184 | 112 | 5 | c86ed59fed687cdaaf7e9c4418d2e3e2c4111cca | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-04 | 184 | 112 | 5 | a6169613c6493b947a176493f542368bfa935dab | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.02e-04 | 184 | 112 | 5 | 51d0447699e3b8f01abbde83f26b748bc9f3c723 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 184 | 112 | 5 | 7c256bcfa07c5ff55aad0833e8712b0456b5832b | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.02e-04 | 184 | 112 | 5 | f7b0bb45a9055ab34e98b251217f6ec38c75ca22 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 184 | 112 | 5 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-04 | 184 | 112 | 5 | cc01c19180861f491a8dc16d60fabd1215fc4525 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-04 | 184 | 112 | 5 | 492c680f0769ba4e651d09c2e8e5d5d271ed08aa | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.02e-04 | 184 | 112 | 5 | 26edbf84216538b80f1ffcc079ee6e385a71fbf9 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 185 | 112 | 5 | 3e3217c99719fd1d2fa94e16be7712a7e5077152 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 185 | 112 | 5 | 0ff4148b4701003d9d594e0da8261176fb13aa59 | |
| ToppCell | COVID-19_Moderate-HSPC|COVID-19_Moderate / disease group, cell group and cell class | 1.05e-04 | 185 | 112 | 5 | cacc6ab5f26f6c803894567fb838ea06eaa7efe5 | |
| ToppCell | (8)_CD34_progenitor|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.07e-04 | 186 | 112 | 5 | 943c604a7cd873faf510096d094100512ba2d6bc | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-04 | 186 | 112 | 5 | bca5215d406f1785bf3a420201d5686071fcaca5 | |
| ToppCell | (8)_CD34_progenitor|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.07e-04 | 186 | 112 | 5 | e69a986b8618effd61875fda528a2e44aab11868 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.10e-04 | 187 | 112 | 5 | f1d0fc625e0e7881b3f290742fd7148d995eb71e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.10e-04 | 187 | 112 | 5 | 02e7246ef5ad41773d14426254e139b156d45c1d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 187 | 112 | 5 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.10e-04 | 187 | 112 | 5 | 08c73d125e0638c9e9878165bba2442c266c8a48 | |
| ToppCell | Healthy-HSPC|World / disease group, cell group and cell class | 1.10e-04 | 187 | 112 | 5 | 8cd9e5499e5c2b2321ecbcf780df37fe0f165ac9 | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 188 | 112 | 5 | 90dc0e15798d0b984518ad58c7e416e30aff687a | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.13e-04 | 188 | 112 | 5 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 188 | 112 | 5 | f63dfd076ced81013918363282ae25cbbd8948ae | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 188 | 112 | 5 | 0554d542149cef654ff1e5e32dfbffd8990b52bd | |
| ToppCell | ASK440-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.16e-04 | 189 | 112 | 5 | 72a19b20cb0f7283afe5f85d62a21cff69fd78d0 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-04 | 189 | 112 | 5 | 358ff514f1c8aa46067208ddf1b68396d789c130 | |
| ToppCell | facs-Heart-LA/RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 189 | 112 | 5 | a08b2d0fa35ffa510050ecffdc68e1b79bbe1632 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.16e-04 | 189 | 112 | 5 | 94dd5d4d815449feff7ce157fe7f8234f7c81422 | |
| ToppCell | facs-Heart-LA/RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 189 | 112 | 5 | efa913d9c16fc32166b484d92b6449e8a0c59e03 | |
| ToppCell | Healthy-HSPC|Healthy / disease group, cell group and cell class | 1.16e-04 | 189 | 112 | 5 | 214b225effc40ca1b83dd8052f2a7b80b65d4938 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 190 | 112 | 5 | cb8798839c27f307955fcc94a1ee40bca95b8e99 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 190 | 112 | 5 | 5bf3d0beee69879c95265d07fba023626a7cc808 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.19e-04 | 190 | 112 | 5 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 191 | 112 | 5 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-04 | 191 | 112 | 5 | b51e0f5d1b93f526160c904e9091313a5364f3a7 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 191 | 112 | 5 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-04 | 191 | 112 | 5 | b270c3dd5952f56b9bdceabe13e298fe6757563b | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 191 | 112 | 5 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 191 | 112 | 5 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 192 | 112 | 5 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| Disease | Liver Cirrhosis, Experimental | PRUNE2 COL5A1 GNPDA1 COL12A1 TCF20 ARMCX1 CD200R1 IQGAP1 GHR CROT ALDH2 ALDH1B1 | 2.72e-05 | 774 | 108 | 12 | C0023893 |
| Disease | drinking behavior | 3.97e-05 | 3 | 108 | 2 | EFO_0004315 | |
| Disease | obsolete_red blood cell distribution width | ATR SPTA1 TUT7 HECTD4 HEMGN KLF3 ADCY9 IQGAP1 EPG5 CEP170 CD22 DNAJA4 KCTD10 ANKRD12 ALDH2 | 1.17e-04 | 1347 | 108 | 15 | EFO_0005192 |
| Disease | adenoid cystic carcinoma (is_implicated_in) | 1.32e-04 | 5 | 108 | 2 | DOID:0080202 (is_implicated_in) | |
| Disease | coronary artery disease | FLT1 CCDC30 TENT5A HECTD4 HEMGN EPG5 RTF1 PARP1 THADA SLC22A1 KCTD10 CAVIN1 ALDH2 | 4.27e-04 | 1194 | 108 | 13 | EFO_0001645 |
| Disease | plasma renin activity measurement | 4.70e-04 | 9 | 108 | 2 | EFO_0006828 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 5.29e-04 | 43 | 108 | 3 | DOID:9261 (is_marker_for) | |
| Disease | glucagon-like peptide-1 measurement | 5.86e-04 | 10 | 108 | 2 | EFO_0008465 | |
| Disease | quality of life during menstruation measurement, acne | 7.14e-04 | 11 | 108 | 2 | EFO_0003894, EFO_0009366 | |
| Disease | alcohol consumption measurement, alcohol drinking | 8.55e-04 | 12 | 108 | 2 | EFO_0004329, EFO_0007878 | |
| Disease | monocyte count | FLT1 TENT5A SPTA1 RTP2 ETF1 PTPN22 ADCY9 NLRP6 CD84 SETD2 THADA KCTD10 ALDH1B1 | 1.08e-03 | 1320 | 108 | 13 | EFO_0005091 |
| Disease | neutrophil count, basophil count | 1.43e-03 | 224 | 108 | 5 | EFO_0004833, EFO_0005090 | |
| Disease | monocyte percentage of leukocytes | 1.48e-03 | 731 | 108 | 9 | EFO_0007989 | |
| Disease | Spondyloepiphyseal Dysplasia | 1.54e-03 | 16 | 108 | 2 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 1.54e-03 | 16 | 108 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 1.54e-03 | 16 | 108 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 1.54e-03 | 16 | 108 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 1.54e-03 | 16 | 108 | 2 | C0025237 | |
| Disease | Van Buchem disease | 1.74e-03 | 17 | 108 | 2 | C0432272 | |
| Disease | neutrophil percentage of leukocytes | 1.84e-03 | 610 | 108 | 8 | EFO_0007990 | |
| Disease | Osteochondrodysplasias | 2.18e-03 | 19 | 108 | 2 | C0029422 | |
| Disease | Dyschondroplasias | 2.18e-03 | 19 | 108 | 2 | C0013366 | |
| Disease | myeloid white cell count | PRUNE2 COL11A1 GNPDA1 ETF1 HECTD4 KLF3 PTPN22 SETD2 THADA ALDH1B1 | 2.33e-03 | 937 | 108 | 10 | EFO_0007988 |
| Disease | Multiple Epiphyseal Dysplasia | 2.42e-03 | 20 | 108 | 2 | C0026760 | |
| Disease | mean arterial pressure | 2.44e-03 | 499 | 108 | 7 | EFO_0006340 | |
| Disease | alcohol drinking | 3.31e-03 | 81 | 108 | 3 | EFO_0004329 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IVYATEKKQTKVEFP | 241 | Q8WZ19 | |
| EEDSKSIKSDVPVYL | 351 | Q5SW79 | |
| KEKKKYETPQREESS | 21 | Q9HCE0 | |
| IVYATEKKQTKVEFP | 231 | Q9H3F6 | |
| YQDEVKLPAKLSISK | 156 | Q6NZI2 | |
| IEVTLAKPVDKDSYV | 296 | Q9NQ94 | |
| AYTEVKTVTIKVPQK | 501 | P30837 | |
| PIEIKTKEVKYDSSL | 31 | Q8N1Q1 | |
| KLISQAYEVLSDPKK | 46 | Q8WW22 | |
| VTDAYTKEKQPKDAV | 1146 | Q6UB98 | |
| IPKTEEEAYALKKIS | 46 | Q8N4T0 | |
| DPDLYIEIVKNTKSV | 626 | Q9UPW5 | |
| IEIVKNTKSVPEYSE | 631 | Q9UPW5 | |
| SPKVVSLKKIYDREQ | 86 | P46940 | |
| DLESVVKKLFTPYTE | 521 | P26374 | |
| VKKLFTPYTETEINE | 526 | P26374 | |
| LISEEDKKTPTSIEY | 381 | Q9Y5P8 | |
| KQTPTKDILTELYKL | 76 | Q68DA7 | |
| DKTYPTTVAEKPKNI | 41 | Q9Y2R2 | |
| SKDPIDVNYEKLKTD | 786 | P09874 | |
| TVKDELTESPKYIQK | 226 | Q8NC51 | |
| ESYEKPISQKKIKIE | 186 | P57682 | |
| TKVKELDPPKTYTQD | 1161 | Q8NEZ4 | |
| TPKLVSEVEELYKSI | 51 | Q8WZ33 | |
| DVKPENLLYTSKEKD | 166 | Q16644 | |
| VDPLYSIKEKETEKS | 266 | P46926 | |
| KEKYTDREELNQTKP | 246 | Q58FF6 | |
| KGYEKTVIEINTPKI | 1761 | P12107 | |
| KDVASEVNLTAYKPK | 481 | Q9H501 | |
| VPAEEITYETLKKAI | 716 | Q9Y2G0 | |
| YETLIKTKEVTDRNP | 341 | Q9NX36 | |
| EEEKVIYRTVNPKSI | 1561 | Q6ZR08 | |
| KYKLNKTESTPVVEE | 271 | Q8TD46 | |
| KEDNEKVPTLLTDYI | 371 | Q99689 | |
| DYIVENEKEKPKSRS | 286 | Q9UGL1 | |
| PTKKQEVPEEKYLTL | 3396 | Q9Y4D8 | |
| SYTPVEVKESDEKTK | 226 | Q9HAS0 | |
| EDLSTETYKNKDVPK | 406 | Q9BXL5 | |
| EEAKPKEITNLYTIT | 276 | Q9UG01 | |
| EVKPSLVIDYLKTEK | 676 | Q460N5 | |
| KPETFSYVTLPKKEE | 461 | Q9P2D7 | |
| EKLIKYATDSETVEP | 1316 | Q13535 | |
| KSDSPNVYTEKKEIA | 411 | Q9ULG6 | |
| QESVKVKIPTSKYTK | 2011 | Q86XA9 | |
| ETSTVLKDLKPETEY | 1436 | Q99715 | |
| LTTSVPVYSLKVDKE | 211 | P10912 | |
| PSLTATEIIYSEVKK | 511 | P13688 | |
| TVQIIAYNKDKESKP | 96 | Q05707 | |
| YKVEVKIKPSTLQVE | 46 | Q96F85 | |
| ELSYLEKVPEVKDTV | 1106 | Q2V2M9 | |
| YDKPVQTVENKETLK | 1106 | O75976 | |
| PTKKQKEIYSTEVFT | 651 | Q5VVM6 | |
| LSKPDYSSIEKIKTI | 1096 | O60503 | |
| TKKGYQKTVLEIDTP | 1791 | P20908 | |
| DKVKPQLEEKTNETY | 21 | P01040 | |
| QPAEIAEKETLEYKT | 221 | Q0VDD8 | |
| TKDTIDISKLPISYK | 71 | Q8IY82 | |
| TILVDSEKEDPIKYN | 811 | Q9UEF7 | |
| VISLVDKYPKEDSEI | 16 | P50053 | |
| AIVSSPEVISKYEKA | 2131 | Q8IWT3 | |
| KQLAKEKPDEYVSSS | 1191 | Q9NZM4 | |
| SVTPTKEFLKDEIKQ | 406 | Q96T23 | |
| KTEPIETKFYETKEE | 456 | Q96T23 | |
| KPKENTIYLKVQTSE | 536 | O15245 | |
| KPDAESVVYLKTETA | 146 | Q9UJQ4 | |
| SKKELPGVLETEVTY | 481 | P59044 | |
| LYESTKDGKVPSEQK | 76 | P20273 | |
| KNYTLIPADIKKDVT | 36 | Q9H756 | |
| PSLEESLKKYLESVK | 26 | Q9UKG9 | |
| AKKQPLKTSEVYSDD | 301 | Q92541 | |
| KPSEKLLEEEVTTYT | 166 | Q5QGT7 | |
| VTEYVVRVPKNTTKK | 11 | P35269 | |
| LVFSPNEEITKIYEK | 1256 | Q93008 | |
| YSKPKETLRAEKSIT | 316 | Q9H9J2 | |
| YKLEQSKSKREPENE | 701 | Q6YHU6 | |
| TKEPEQIKSEYKEER | 2521 | Q8WUY3 | |
| KEDIKRVSPYSSLTK | 246 | Q6ZSM3 | |
| KVNPKTDKPYEDVSI | 626 | Q96BP3 | |
| YDEILQSKVLPSKEE | 296 | Q9UIB8 | |
| EKSTSKYEVLTVQEP | 386 | Q96T21 | |
| NYIKPEDKKVESTPT | 1091 | Q8NFU7 | |
| YALEVEKITTSKKPN | 1006 | P53396 | |
| AYTEVKTVTVKVPQK | 501 | P05091 | |
| REKSKKYSDVEVPAS | 401 | P35611 | |
| IKTKDPIIREKTYNA | 256 | Q9P291 | |
| KDTEYKKTDICIPQT | 501 | O14967 | |
| EIKEESDYISTKKTI | 1111 | A4UGR9 | |
| KDKQSYRDLKEVTPE | 226 | P22234 | |
| EVQGKYVKKETSPLL | 16 | Q9H4B6 | |
| IKLYRETNEPVKTKT | 286 | P12956 | |
| DIYKQESTRPEKKSD | 106 | Q9BYV6 | |
| SQQDIYGEKIPKESK | 56 | Q8NEP9 | |
| EKDKKIQSYLLTAPI | 431 | Q8N9B8 | |
| SEADKYQPLSLVVKK | 26 | Q0ZLH3 | |
| QAKKEKEPEYTLLTE | 296 | O95793 | |
| KENSYPKEADIVIKS | 251 | Q9H6T3 | |
| SEIQNIKSELKYVPK | 71 | Q9UHP9 | |
| YAKVEKSIKSDDSQP | 311 | Q8NEM7 | |
| EKVNILTDKSYEDPT | 71 | P02549 | |
| SDTEEIKPQTKKETY | 41 | Q4ZJI4 | |
| EIKLKYATQPLDKTD | 1611 | Q9UGU0 | |
| EVYRIPKKSQTEKEN | 2021 | Q9BYW2 | |
| KTINPQVSKTEYKEL | 31 | Q13296 | |
| PDLETKYETKKLSLE | 76 | Q8N141 | |
| IAKELSKTYQETPEI | 451 | O96006 | |
| TEFIKKKIEEVSNTP | 1006 | Q8IWB9 | |
| NKYTEREVSTKEDKP | 1396 | Q5VYS8 | |
| AVPTSKKKETESAIY | 111 | P17948 | |
| KEEQEEPYVSLTRKK | 126 | Q6PP77 | |
| EKITPLTLKEAYVQK | 176 | Q96IP4 | |
| KSVKEDTSTLPVIYK | 236 | Q6NT04 | |
| SFKSPQVYLKEEEEK | 61 | O00124 | |
| EKKYKRQPEESESKT | 126 | P18583 | |
| EKILYLTPEQEKDKS | 341 | P62495 | |
| YAVKIIDKSKRDPSE | 441 | Q15349 |